You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IL6

Showing 351 - 375 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Distress Syndrome, Acute Trial in Ocean Springs (GEn-1124, Placebo)

Recruiting
  • Respiratory Distress Syndrome, Acute
  • Ocean Springs, Mississippi
    Ocean Springs Hospital
Apr 3, 2023

Obesity Trial (Moderate exercise, Rest)

Recruiting
  • Obesity
  • Moderate exercise
  • Rest
  • Gatineau, Quebec, Canada
    Aurelie Baillot
Oct 31, 2022

Acute Bronchitis Trial in Seoul (Bronpass Tab., Placebo of Erdos capsule, Erdos capsule)

Completed
  • Acute Bronchitis
  • Bronpass Tab.
  • +3 more
  • Seoul, Korea, Republic of
    Konkuk University Hospital
Sep 12, 2023

Post-COVID-19 Syndrome, Postural Tachycardia Syndrome, Dysautonomia Trial in New York (Non-invasive vagus nerve stimulation,

Recruiting
  • Post-COVID-19 Syndrome
  • +2 more
  • Non-invasive vagus nerve stimulation
  • Sham Intervention
  • New York, New York
    Abilities Research Center
Nov 21, 2022

Solid Tumors Trial in Guangzhou (MASCT-I injection)

Completed
  • Solid Tumors
  • MASCT-I injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
May 25, 2023

Biomarkers of Metabolic Obesity.

Completed
  • Obesity
    • Białystok, Poland
      Medical University of Bialystok
    Nov 3, 2022

    Healthy Subjects Trial in Charlottesville (Ultrasound stimulation intensity, Ultrasound stimulation site)

    Recruiting
    • Healthy Subjects
    • Ultrasound stimulation intensity
    • Ultrasound stimulation site
    • Charlottesville, Virginia
      University of Virginia, Division of Nephrology; Center for Immun
    Jan 6, 2023

    Type 2 Diabetes, NAFLD Trial (Drinking powder supplement)

    Not yet recruiting
    • Type 2 Diabetes
    • NAFLD
    • Drinking powder supplement
    • (no location specified)
    Dec 8, 2022

    Aging, Sarcopenia, Nutrition, Healthy Trial in Burgos (CRE + HMB, CRE + GAA, Placebo)

    Not yet recruiting
    • Aging
    • +2 more
    • CRE + HMB
    • +2 more
    • Burgos, Spain
      Juan Mielgo Ayuso
    Jul 10, 2023

    Behind Severe Insulin Resistance During Pregnancy in Glucose

    Recruiting
    • Diabetes Mellitus, Type 2
    • +6 more
    • No interventions
    • Aarhus, Aarhus N, Denmark
    • +1 more
    Nov 22, 2022

    KSHV Inflammatory Cytokine Syndrome (KICS), Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease Trial run by

    Not yet recruiting
    • KSHV Inflammatory Cytokine Syndrome (KICS)
    • Kaposi Sarcoma Herpesvirus -Associated Multicentric Castleman Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Oct 2, 2023

    Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

    Not yet recruiting
    • Relapse
    • +7 more
    • Visakhapatnam, Andhra Pradesh, India
    • +5 more
    May 7, 2023

    Acute Ischemic Stroke Trial in Cheras (Neuroncell-EX, Placebo)

    Not yet recruiting
    • Acute Ischemic Stroke
    • Neuroncell-EX
    • Placebo
    • Cheras, Wilayah Persekutuan Kuala Lumpur, Malaysia
      Hospital Canselor Tuanku Muhriz UKM
    Nov 13, 2023

    Stress, Inflammation and Neuroimaging in Major Depressive

    Not yet recruiting
    • MDD
    • PMDD
      • Tübingen, Baden-Württemberg, Germany
        University Hospital Tübingen, Klinik für Psychiatrie und Psychot
      Nov 13, 2023

      Esophagus Cancer, Bladder Cancer, Liver Cancer Trial (Intravenous injection of P-IL-2, P-IL-2 plus Anti-PD-1 Monoclonal

      Not yet recruiting
      • Esophagus Cancer
      • +4 more
      • Intravenous injection of P-IL-2
      • P-IL-2 plus Anti-PD-1 Monoclonal Antibody
      • (no location specified)
      Apr 24, 2023

      Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant

      Not yet recruiting
      • Breast Cancer Triple Negative
      • +3 more
        • Atlanta, Georgia
          Emory University/Winship Cancer Institute
        May 18, 2023

        Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)

        Recruiting
        • Digestive System Neoplasms
        • iNeo-Vac-R01
        • Hangzhou, Zhejiang, China
          Department of General Surgery, Institute of Minimally Invasive S
        Sep 8, 2023

        To Evaluate the Clinical Efficacy and Safety of the New ALSS Trial in Wuhan (New artificial liver CABA system (BS330+CA280) +PE)

        Recruiting
        • To Evaluate the Clinical Efficacy and Safety of the New ALSS
        • New artificial liver CABA system (BS330+CA280) +PE
        • Wuhan, Hubei, China
          Tongji Hospital
        Mar 21, 2023

        Surgically Treated Patients With Laryngeal Cancer

        Recruiting
        • Oxidative Stress Induction
        • +5 more
        • Analgesics, Opioid
        • Analgesics, Non-Narcotic
        • Belgrade, Serbia
        • +1 more
        May 10, 2023

        Risk Factors in Progressive Pulmonary Fibrosis

        Not yet recruiting
        • Interstitial Lung Disease
          • (no location specified)
          Jun 7, 2023

          Post Traumatic Stress Disorder, Inflammation Trial in Denver (Lactobacillus rhamnosus GG (LGG; ATCC strain 53103; CRMTS #11272;

          Recruiting
          • Post Traumatic Stress Disorder
          • Inflammation
          • Lactobacillus rhamnosus GG (LGG; ATCC strain 53103; CRMTS #11272; PTS #3766)
          • Placebo
          • Denver, Colorado
            VA Rocky Mountain Regional Center
          Dec 14, 2022

          Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

          Recruiting
          • Head and Neck Squamous Cell Carcinoma
          • inulin
          • +2 more
          • Candiolo, Turin, Italy
            Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
          Apr 7, 2023

          Keratoconus Trial in Valencia (Highly-concentrated DHA triglyceride (Tridocosahexanoin-AOX 70%))

          Completed
          • Keratoconus
          • Highly-concentrated DHA triglyceride (Tridocosahexanoin-AOX 70%)
          • Valencia, Spain
            FISABIO Medical Ophthalmology (FOM)
          Feb 23, 2023

          Oxidative Stress, Inflammation Trial in Ede (Vitamin K2, Placebo)

          Active, not recruiting
          • Oxidative Stress
          • Inflammation
          • Vitamin K2
          • Placebo
          • Ede, Netherlands
            NIZO food research
          Feb 2, 2023

          Type 2 Diabetes Trial in Nanjing (Tirzepatide, Insulin Glargine)

          Recruiting
          • Type 2 Diabetes Mellitus
          • Nanjing, Jiangsu, China
            Nanjing First Hospital
          Sep 21, 2022